Kolberg et al. [10] defined a prognostic test for post-tumor resection MPNST patients, based on expression of three proteins encoded by genes located in the distal part of chromosome 17q (BIRC5, TK1, TOP2A). Here, BIRC5 is linked to malignant peripheral nerve sheath tumor.